0.00Open0.00Pre Close0 Volume0 Open Interest9.00Strike Price0.00Turnover76.17%IV-45.63%PremiumSep 20, 2024Expiry Date2.82Intrinsic Value100Multiplier27DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9700Delta0.0957Gamma2.19Leverage Ratio-0.0011Theta-0.0020Rho-2.12Eff Leverage0.0011Vega
LifeStance Health Stock Discussion
TQ2 '24: Net loss: $23.3m Revenue: $312.3m, up 20% YoY Clinician base: Up 14% to 6,984 Visit volumes: Up 15% to 2m Adj. EBITDA: $28.6m, up 103% YoY '24 guidance: Rev. $1.2b-$1.242b, Center Margin $363m-$383m, Adj. EBITDA $90m-$100m.
No comment yet